This article needs more citations. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Spasmolytic A29" – news · newspapers · books · scholar · JSTOR (January 2025) (Learn how and when to remove this message) |
| Clinical data | |
|---|---|
| Other names | N,N-Dimethyl-4,4-diphenylbut-3-en-2-amine |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C18H21N |
| Molar mass | 251.373 g·mol−1 |
| 3D model (JSmol) | |
| |
A29 is a spasmolytic drug. It not used by itself but is co-administered with ketobemidone in a formulation sold as Ketogan. It is an analog of both amitriptyline and diphenhydramine.
| By region/system |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Measurement and testing | |||||||||||
| Pathophysiology | |||||||||||
| Management | |||||||||||
| Related concepts | |||||||||||